Hisamitsu Pharmaceutical Co Inc (4530.T)

4530.T on Tokyo Stock Exchange

17 May 2019
Change (% chg)

¥145 (+3.27%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Hisamitsu Pharmaceutical to set up pharmaceutical import and sales unit in Hong Kong
Thursday, 8 Feb 2018 

Feb 8 (Reuters) - Hisamitsu Pharmaceutical Co Inc <4530.T>:Says it will set up a wholly owned pharmaceutical import and sales unit, Hisamitsu Pharmaceutical (Hong Kong) Co., Limited, in February .Says the unit will be capitalized at 10 million yen .  Full Article

Noven files patent infringement lawsuit against Alvogen
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - ‍Noven Pharmaceuticals :‍Noven Pharmaceuticals says filed lawsuit in a U.S. court against Alvogen and Alvogen pine brook llc for patent infringement.Says Alvogen is seeking approval to market & sell generic version of Minivelle prior to expiration of 2 of Noven's orange book listed patents​.  Full Article

Hisamitsu Pharmaceutical to set up subsidiary in China
Tuesday, 8 Aug 2017 

Aug 8 (Reuters) - Hisamitsu Pharmaceutical Co Inc <4530.T>:* Says it will set up a wholly owned subsidiary in China in August .* New subsidiary will be engaged in import and sale of pharmaceuticals.* New subsidiary will be capitalized at 1 billion yen.  Full Article

Hisamitsu Pharmaceutical's sales for March-May qtr seen down 8 pct - Nikkei
Thursday, 22 Jun 2017 

June 22 (Reuters) - Nikkei: :Hisamitsu Pharmaceutical's group operating profit appears to have declined 13% on the year to just under 5 billion yen for March-May quarter - Nikkei.Hisamitsu Pharmaceutical's sales for March-May quarter are seen down 8% at about 35 billion yen - Nikkei.Hisamitsu Pharmaceutical Co Inc will likely maintain its forecast for the full year ending February 2018 - Nikkei.  Full Article